Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |